For instance, a recent study of MEK inhibition in patients with epithelioid hemangioendothelioma demonstrated limited RECIST responses, yet patients reported a significant reduction in pain intensity.23 The gene discussed is MAP2K7; the disease is epithelioid hemangioendothelioma.